Skip to search formSkip to main contentSkip to account menu

Nitroglycerin Transdermal System

Known as: GTN Transdermal Patch, Glyceryl Trinitrate Transdermal Patch, Nitroglycerin Transdermal Patch 
A sustained release transdermal patch containing the organic nitrate nitroglycerin, with vasodilator and potential immunomodulating activities. Upon… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Chronically administered organic nitrates induce nitrate tolerance and endothelial dysfunction, which limit their therapeutic use… 
2011
2011
To elucidate the mechanism underlying reduction of nitroglycerin (GTN) to nitric oxide (NO) by mitochondrial aldehyde… 
2010
2010
ted patients. Efficacy was better than that of nifedipine and amlodipine (33 vs 25% response rate, respectively), but small… 
Review
2008
Review
2008
Hedetniemi’s conjecture states that the chromatic number of a categorical product of graphs is equal to the minimum of the… 
2002
2002
Animals treated with nitric oxide synthase (NOS) inhibitors exhibit marked hypersensitivity to the blood pressure lowering… 
2000
2000
Summary The pharmaceutical development and characteristics of the new glyceryl trinitrate (GTN, CAS 55-63-0) transdermal patch… 
1999
1999
BACKGROUND AND AIM Since functional properties in the vasculature of hypercholesterolemic subjects are impaired, a six-month… 
1998
1998
ABSTRACT Nitroglycerin (glycerol trinitrate [GTN]), an explosive and vasodilatory compound, was metabolized by mixed microbial… 
1998
1998
Glyceryl trinitrate (GTN) is a potent smooth muscle relaxant and vasodilator. There are conflicting reports regarding its…